PLACEBO-CONTROLLED, DOUBLE-BLIND, TWO-CENTRE TRIAL OF KETANSERIN IN INTERMITTENT CLAUDICATION
- 1 December 1985
- journal article
- research article
- Published by Elsevier in The Lancet
- Vol. 326 (8467) , 1268-1271
- https://doi.org/10.1016/s0140-6736(85)91553-3
Abstract
No abstract availableThis publication has 10 references indexed in Scilit:
- PLACEBO-CONTROLLED DOUBLE-BLIND TRIAL OF KETANSERIN IN TREATMENT OF INTERMITTENT CLAUDICATIONThe Lancet, 1984
- Antihypertensive Action and Serotonin-Induced Platelet Aggregation During Long-Term Ketanserin Treatment in Hypertensive PatientsJournal of Cardiovascular Pharmacology, 1984
- Platelet-mediated vascular contractions: Inhibition of the serotonergic component by ketanserinThrombosis Research, 1982
- Current Therapy for Intermittent ClaudicationDrugs, 1982
- Pentoxifylline efficacy in the treatment of intermittent claudication: Multicenter controlled double-blind trial with objective assessment of chronic occlusive arterial disease patientsAmerican Heart Journal, 1982
- Treatment of hypertension with ketanserin, a new selective 5-HT2 receptor antagonist.BMJ, 1982
- Vasodilator Drugs in Peripheral Vascular DiseaseNew England Journal of Medicine, 1979
- Semicontinuous blood flow measurement by triggered venous occlusion plethysmography.Journal of Applied Physiology, 1971
- The aggregation of blood plateletsThe Journal of Physiology, 1963